Assessing possible hazards of reducing serum cholesterol

BMJ

Volumn 308, Issue 6925, 1994, Pages 373-

  Law, M R ^a   Thompson, S G ^a   Wald, N J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STROKE; UNITED KINGDOM;

ACCIDENTS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHOLESTEROL; COHORT STUDIES; FEMALE; HUMANS; MALE; NEOPLASMS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SUICIDE;

EID: 0028181727     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.308.6925.373     Document Type: Article

References (51)

1. Law MR Wald NJ Thompson SG.By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994; 308: 367–72
2. Jacobs D Blackburn H Higgins M Reed D Iso H McMillan G, et al. Report of the conference on low blood cholesterol: mortality associations Circulation 1992; 86: 1046–60.
3. Oliver MF. Reducing cholesterol does not reduce mortality. J Am Coll Cardiol 1988; 12: 814–7.
4. Ravnskov U. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. BMJ 1992; 305: 15–9.
5. Muldoon MF Manuck SB Matthews KA. Lowering cholesterol concentration and mortality: a quantitative review of primary prevention trials. BMJ 1990; 301: 309–14.
6. Davey Smith G Song F Sheldon TA. Cholesterol lowering and mortality: The importance of considering initial level of risk. BMJ 1993; 306: 1367–73.
7. Davey Smith G Pekkanen J.Should there be a moratorium on the use of cholesterol lowering drugs? BMJ 1992; 304: 431–4.
8. Davey Smith G Shipley MJ Marmot MG Rose G. Plasma cholesterol concentration and mortality: The Whitehall study. JAMA 1992; 267: 70–6.
9. Dyer AR Stamler J Paul O Shekelle RB Schoenberger JA Berkson DM, et al. Serum cholesterol and risk of death from cancer and other causes in three Chicago epidemiological studies. Journal of Chronic Diseases 1981; 34: 249–60.
10. Neaton JD Blackburn H Jacobs D Kuller L Lee DJ Sherwin R, et al. Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial. Arch Intern Med 1992; 152: 1490–500.
11. Frank JW Reed DM Grove JS Benfante R. Will lowering population levels of serum cholesterol affect total mortality? J Clin Epidemiol 1992; 45: 333–46.
12. Lindberg G Rastam L Gullberg B Eklund GA. Low serum cholesterol concentration and short term mortality from injuries in men and women. BMJ 1992; 305: 277–9.
13. Keys A. Seven countries: a multivariate analysis of death and coronary heart disease. Cambridge, Massachusets: Harvard University Press, 1980.
14. Menotti A Keys A Blackburn H Aravanis C Dontas A Fidanza F, et al. Twenty-year stroke mortality and prediction in twelve cohorts of the seven countries study. Int J Epidemiol 1990; 19: 309–15.
15. Law MR Wald NJ. An ecological study of serum cholesterol and ischaemic heart disease between 1950 and 1990. Eur J Clin Nutr (in press).
16. Wysowski DK Gross TP. Deaths due to accidents and violence in two recent trials of cholesterol-lowering drugs. Arch Intern Med 1990; 150: 2169–72.
17. The Lipid Research Clinics Investigators. The lipid research clinics coronary primary prevention trial: results of 6 years of post-trial follow-up. Arch Intern Med 1992; 152: 1399–410.
18. Dewar HA Oliver MF. Trial of clofibrate. BMJ 1972; i: 506.
19. Pearce ML Dayton S. Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet 1971; i: 464–7.
20. Heady JA. Are PUFA harmful? BMJ 1974; i: 115–6.
21. Leren P. The Oslo diet-heart study: eleven year report. Circulation 1970; 42: 935–42.
22. Persson B Johansson BW. The Kockum study: twenty-two-year follow-up. Acta Med Scand 1984; 216: 485–93.
23. Westlund K Nicolaysen R. Ten-year mortality and morbidity related to serum cholesterol. Scand J Clin Lab Invest 1972; 30(suppl 127):1–24.
24. Klag MJ Ford DE Mead LA He J Whelton PK Liang K-Y, et al. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med 1993; 328: 313–8.
25. Baptiste MS Nasca PC Doyle JT Rothenberg RR MacCubbin PA Mettlin C, et al. Cholesterol and cancer in a population of male civil service workers. Int J Epidemiol 1992; 21: 16–21.
26. Cambien F Ducimetiere P Richard J. Total serum cholesterol and cancer mortality in a middle-aged male population. Am J Epidemiol 1980; 112: 388–94.
27. Hole DJ Davey Smith G Watt GCM Hart CL Gillis CR Hawthorne VM. Low cholesterol and mortality: demonstration of a health selection effect. J Epidemiol Community Health 1993; 47: 402.
28. Iso H Jacobs DR Wentworth D Neaton JD Cohen JD. Serum cholesterol levels and six-year mortality from stroke in 350, 977 men screened for the multiple risk factor intervention trial. N Engl J Med 1989; 320: 904–10.
29. Tanaka H Ueda Y Hayashi M Date C Baba T Yamashita H, et al. Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke 1982; 13: 62–73.
30. Ueshima H Lida M Shimamoto T Konishi M Tsujioka K Tanigaki M, et al. Multivariate analysis of risk factors for stroke: eight-year follow-up study of farming villages in Akita, Japan. Prev Med 1980; 9: 722–40.
31. Takeya Y Popper JS Shimizu Y Kato H Rhoads GG Kagan A. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: incidence of stroke in Japan and Hawaii. Stroke 1984; 15: 15–23.
32. Szatrowski TP Peterson AV Shimizu Y Prentice RL Mason MW Fukunaga Y, et al. Serum cholesterol, other risk factors and cardiovascular disease in a Japanese cohort. Journal of Chronic Diseases 1984; 37: 569–84.
33. Chen Z Peto R Collins R MacMahon S Lu J Li W. Serum cholesterol concentration and coronary heart disease in a population with low cholesterol concentrations. BMJ 1991; 303: 276–82.
34. Shimamoto T Komachi Y Inada H Doi M Iso H Sato S, et al. Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation 1989; 79: 503–15.
35. Blackburn H Jacobs DR. The ongoing natural experiment of cardiovascular diseases in Japan. Circulation 1989; 79: 718–20.
36. Ooneda G Yoshida Y Suzuki K Shinkai H Hori S Kobori K, et al. Smooth muscle cells in the development of plasmatic arterionecrosis, arteriosclerosis and arterial contraction. Blood Vessels 1978; 15: 148–56.
37. Law MR Thompson SG. Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies. Cancer Causes Control 1991; 2: 253–61.
38. Peto R Boreham J Chen J Li J Campbell TC Brun T. Plasma cholesterol, coronary heart disease and cancer. BMJ 1989; 298: 1249.
39. Prentice RL Sheppard L. Dietary fat and cancer: consistency of the epidemiologic data, and disease prevention that may follow from a practical reduction in fat consumption. Cancer Causes Control 1990; 1: 81–97.
40. Wynder EL Hebert JR Kabat GC. Association of dietary fat and lung cancer. J Natl Cancer Inst 1987; 79: 631–7.
41. Gregory J Foster K Tyler, H Wiseman M. The dietary and nutritional survey of British adults. London: HMSO, 1990.
42. Morgan RE Palinkas LA Barrett-Connor EL Wingard DL. Plasma cholesterol and depressive symptoms in older men. Lancet 1993; 341: 75–9.
43. Glueck CJ Sanghvi VR Laemmle P Unger L McCray C Tracy T, et al. Lack of concordance in classification of coronary heart disease risk. J Lab Clin Med 1990; 116: 377–85.
44. Goble AJ Worcester MC. Low serum cholesterol and violent death. BMJ 1992; 305: 773.
45. Magni G Garreau M Orofiamma B Palminteri R. Fengabine, a new GABAmimetic agent in the treatment of depressive disorders: an overview of six double-blind studies versus tricyclics. Neuropsychobiology 1988; 20: 126–31.
46. Downs JR Oster G Santanello NC. HMG CoA reductase inhibitors and quality of life. JAMA 1993; 269: 3107–8.
47. Dujovne CA Chremos AN Pool JL Schnaper H Bradford RH Shear CL, et al. Expanded clinical evaluation of lovastatin (EXCEL) study results. IV. Additional perspectives on the tolerability of lovastatin. Am J Med 1991; 91(supple I B):25S–30S.
48. Seppa K Sillanaukee P Pitkajarvi T Nikkila M Kiovula T. Moderate and heavy alcohol consumption have no favourable effect on lipid values. Arch Intern Med 1992; 152: 297–300.
49. Chen Z Keech A Collins R Slavin B Chen J Campbell TC, et al. Prolonged infection with hepatitis B virus and association between low blood cholesterol and liver cancer. BMJ 1993; 306: 890–4.
50. Kerttula Y Weber T. Serum lipids in pneumonia of different aetiology. Annals of Clinical Research 1988; 20: 184–8.
51. Alvarez C Ramos A. Lipids, lipoproteins, and apolipoproteins in serum during infection. Clin Chem 1986; 32: 142–5.